Stay updated on Sage-217 Efficacy in MDD Clinical Trial
Sign up to get notified when there's something new on the Sage-217 Efficacy in MDD Clinical Trial page.

Latest updates to the Sage-217 Efficacy in MDD Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedFooter shows Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe government funding status notice banner was removed, and this does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check33 days agoChange DetectedBiogen is now listed as the sponsor following a transfer from Sage Therapeutics, and the study results were posted (Results First Posted 2023-12-05).SummaryDifference0.3%

- Check62 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference3%

- Check69 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with updated versioning rather than new substantive information in the deleted areas.SummaryDifference0.3%

- Check83 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Sage-217 Efficacy in MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sage-217 Efficacy in MDD Clinical Trial page.